Große-Berkenbusch Katharina, Avci-Adali Meltem, Cahalan Patrick, Cahalan Linda, Velic Ana, Maček Boris, Schlensak Christian, Wendel Hans Peter, Stoppelkamp Sandra
Clinical Research Laboratory, Department of Thoracic and Cardiovascular Surgery, University Hospital Tübingen, Tübingen University, Tübingen, Germany.
Ension Inc., Butler, PA, United States.
Front Cardiovasc Med. 2025 Jun 17;12:1578538. doi: 10.3389/fcvm.2025.1578538. eCollection 2025.
Artificial lungs support patients with acute or chronic lung diseases. However, complications such as the activation of blood components leading to thrombosis and inflammation limit their long-term applicability. The systematic characterization of protein adhesion events on different material parts of the oxygenators at different flow rates can shed light on the initial reaction of blood to foreign materials. Miniaturized extracorporeal circuit devices with heparin-coated gas (PMP) or heat-exchange (PET) hollow-fiber membranes were exposed to high and low flow rates. Hemocompatibility and adsorption of plasma proteins were measured after one minute to six hours using mass spectroscopy analyses. Approximately 150-200 different proteins were present on the membranes, with almost no variation in the 10 most abundant proteins. Protein adsorption to the membrane types did not vary to a large extent, but a decreased flow rate significantly reduced the differences in protein adsorption between both membrane types and led to the adhesion of significantly higher amounts of inhibitory proteins C1INH and α1-AT. At the higher flow rate, coagulation-associated proteins adsorbed significantly more to PET membranes, whereas complement-activating-related proteins adsorbed more on PMP membranes. Our results highlight the importance of analyzing all circuit components to understand the activation of blood components during ECMO. The primary contributor to increased protein adsorption and activation of blood components was an increased flow rate. Therefore, flow rate adjustments should ideally aim to achieve optimal oxygenation levels of around 80% while minimizing protein adsorption and blood activation during ECMO. Notably, at a low flow rate, PMP HFM exhibited a significant increase in binding of complement and inflammation inhibitors, suggesting a potential benefit of lowering the flow rate apart from the general reduction in protein adsorption.
人工肺用于支持患有急性或慢性肺部疾病的患者。然而,诸如血液成分激活导致血栓形成和炎症等并发症限制了它们的长期适用性。系统地表征不同流速下氧合器不同材料部分上的蛋白质粘附事件,有助于了解血液对外来材料的初始反应。将带有肝素涂层的气体(PMP)或热交换(PET)中空纤维膜的小型体外循环装置暴露于高流速和低流速下。使用质谱分析在1分钟至6小时后测量血液相容性和血浆蛋白吸附情况。膜上存在约150 - 200种不同的蛋白质,其中含量最高的10种蛋白质几乎没有变化。蛋白质对这两种膜类型的吸附在很大程度上没有差异,但流速降低显著减少了两种膜类型之间蛋白质吸附的差异,并导致显著更多数量的抑制性蛋白质C1INH和α1 - AT的粘附。在较高流速下,与凝血相关的蛋白质在PET膜上的吸附明显更多,而与补体激活相关的蛋白质在PMP膜上吸附更多。我们的结果强调了分析所有循环组件以了解体外膜肺氧合(ECMO)期间血液成分激活的重要性。蛋白质吸附增加和血液成分激活的主要因素是流速增加。因此,流速调整理想情况下应旨在实现约80%的最佳氧合水平,同时在ECMO期间将蛋白质吸附和血液激活降至最低。值得注意的是,在低流速下,PMP中空纤维膜表现出补体和炎症抑制剂结合的显著增加,这表明除了蛋白质吸附普遍减少之外,降低流速可能还有潜在益处。